Results 151 to 160 of about 1,408,984 (372)

Risk for prescription opioid misuse among patients with a history of substance use disorder [PDF]

open access: green, 2012
Benjamin J. Morasco   +3 more
openalex   +1 more source

A Comprehensive Review on Capillary Electrophoresis–Mass Spectrometry in Advancing Biomolecular Research

open access: yesELECTROPHORESIS, EarlyView.
ABSTRACT This review provides an in‐depth exploration of capillary electrophoresis–mass spectrometry (CE–MS) in biomolecular research from 2020 to 2024. CE–MS emerges as a versatile and powerful tool due to its numerous advantages, facilitating the analysis of various biomolecules, including proteins, peptides, oligonucleotides, and other metabolites ...
Laura Pont   +2 more
wiley   +1 more source

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study

open access: yesRural and Remote Health
Introduction: Rates of N-methylamphetamine (methamphetamine) use in rural areas of the US have been steadily increasing, particularly among individuals who are already struggling with opioid use disorder.
Leslie Kenefick   +9 more
doaj   +1 more source

Mental Health Disorders and Long-term Opioid Use Among Adolescents and Young Adults With Chronic Pain [PDF]

open access: green, 2012
Laura Richardson   +7 more
openalex   +1 more source

Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic–clonic seizures

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Evaluating the efficacy of an opioid antagonist, naloxone (NLX), to reduce the severity of post‐ictal hypoxemia and immobility after focal to bilateral tonic–clonic seizures (FBTCS). Methods ENALEPSY is a double‐blind placebo (PCB)‐controlled trial conducted in patients with focal epilepsy undergoing long‐term video‐EEG monitoring ...
Sylvain Rheims   +71 more
wiley   +1 more source

Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure

open access: yesNutrition in Clinical Practice, Volume 38, Issue 1, Page 129-137, February 2023., 2023
Abstract Background Chronic analgesic use is described in home parenteral nutrition (HPN)–dependent patients, but there are limited data on factors associated with opioid use for noncancerous pain. Methods Patients attending a national UK intestinal failure reference center were divided in two groups according to strong opioid (SO) usage; risk factors ...
Liat Deutsch   +7 more
wiley   +1 more source

Associations between pain-management treatments and opioid use disorder risk among Medicaid patients [PDF]

open access: yesarXiv
Introduction: Chronic pain patients are at increased risk of opioid-misuse. Less is known about the unique risk conferred by each pain-management treatment, as treatments are typically implemented together, confounding their independent effects. We estimated the extent to which pain-management strategies were associated with risk of incident opioid use
arxiv  

Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol [PDF]

open access: green, 2013
Wilson M. Compton   +3 more
openalex   +1 more source

Organ‐on‐Chip: The Future of Nutrition Research in a One Health World

open access: yesFood Frontiers, EarlyView.
Organ‐on‐chips offer a promising tool for evaluating food and feed safety. Organ‐on‐chips also present a scientifically robust and ethical alternative to animal studies. ABSTRACT The One Health approach emphasizes the interconnectedness of human, animal, and environmental health, recognizing that the health of each is interdependent and influenced by ...
Manuela Cassotta   +8 more
wiley   +1 more source

Central monitoring of depression and anxiety symptoms reduces placebo responses in depression clinical trials: A post hoc exploratory analysis of data from the phase III CCT‐004 trial of vortioxetine

open access: yesNeuropsychopharmacology Reports, Volume 42, Issue 4, Page 468-477, December 2022., 2022
Abstract Aim Clinical trials of antidepressants often fail to demonstrate their efficacy versus placebo, suggesting that patient selection based on physician ratings of depression may contribute to a high placebo response. Methods In the CCT‐004 trial of vortioxetine, central monitoring was employed to compare physician and patient ratings of ...
Yoshinori Watanabe   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy